首页>
外国专利>
NOVEL NANOTECHNOLOGY-DRIVEN PROTOTYPES FOR AI-ENRICHED BIOCOMPATIBLE PROSTHETICS FOLLOWING EITHER RISK OF ORGAN FAILURE OR MODERATE TO SEVERE IMPAIRMENT
NOVEL NANOTECHNOLOGY-DRIVEN PROTOTYPES FOR AI-ENRICHED BIOCOMPATIBLE PROSTHETICS FOLLOWING EITHER RISK OF ORGAN FAILURE OR MODERATE TO SEVERE IMPAIRMENT
Three groups of biocompatible implants were created, to leverage physiological impairment caused by (i) cardiovascular, (ii) renal, and (iii) neuronal diseases. Each group of implants is subdivided into three categories according to extra functionality added plus integrated additions. The first generation contains basic functionality and the second and third generations contain extra functions. Finally, further additions can be combined and integrated. Therefore, the first group comprises of the "First Generation of Cardiovascular Implants" plus the "Second Generation of Cardiovascular Implants" plus the "Third Generation of Cardiovascular Implants" plus additional integrations named "Additions". Equally, the second group comprises of the "First", the "Second" and the "Third" Generation of Renal Prosthetics plus Additions. The same categorisation applies to Neural Implants, which are three generations plus additions. This can be found in the description of claims presented in the Austrian Prio (provisional patent application) number A 60273/2019, from 11th December 2019.
展开▼